Yoshihiro Ogawa - Kobayashi Pharmaceutical Sr Division

KBYPFDelisted Stock  USD 32.49  0.00  0.00%   

Insider

Yoshihiro Ogawa is Sr Division of Kobayashi Pharmaceutical Co
Phone81 6 6222 0142
Webhttps://www.kobayashi.co.jp

Kobayashi Pharmaceutical Management Efficiency

The company has return on total asset (ROA) of 0.0633 % which means that it generated a profit of $0.0633 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0968 %, meaning that it generated $0.0968 on every $100 dollars invested by stockholders. Kobayashi Pharmaceutical's management efficiency ratios could be used to measure how well Kobayashi Pharmaceutical manages its routine affairs as well as how well it operates its assets and liabilities.
Kobayashi Pharmaceutical Co has accumulated 596 M in total debt with debt to equity ratio (D/E) of 0.0, which may suggest the company is not taking enough advantage from borrowing. Kobayashi Pharmaceutical has a current ratio of 3.84, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Kobayashi Pharmaceutical until it has trouble settling it off, either with new capital or with free cash flow. So, Kobayashi Pharmaceutical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Kobayashi Pharmaceutical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Kobayashi to invest in growth at high rates of return. When we think about Kobayashi Pharmaceutical's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Shmulik LevyRami Levi Chain
61
Pamela BurkeGrocery Outlet Holding
57
Dawn PhillipsonArhaus Inc
43
Adam FriedlerRami Levi Chain
N/A
Nicholas PartenzaCedar Realty Trust
N/A
Yafit AtiasRami Levi Chain
40
Jennifer PorterArhaus Inc
42
Adina LevyRami Levi Chain
63
Crystal PlumCedar Realty Trust
41
John ReedArhaus Inc
70
Layla KashaGrocery Outlet Holding
N/A
Sandler OhadRami Levi Chain
N/A
Todd SchivelyCedar Realty Trust
N/A
Gareth LockeMYT Netherlands Parent
49
Brad CohenCedar Realty Trust
N/A
Rami LevyRami Levi Chain
68
Tim KuckelmanArhaus Inc
58
Dawn SparksArhaus Inc
61
Martin BeerMYT Netherlands Parent
56
Michael FranklinCedar Realty Trust
42
SaydoffBarashi InbalRami Levi Chain
46
Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells consumer products in Japan and internationally. Kobayashi Pharmaceutical Co., Ltd. was founded in 1886 and is headquartered in Osaka, Japan. Kobayashi Pharmaceutical operates under Household Personal Products classification in the United States and is traded on OTC Exchange. It employs 3451 people. Kobayashi Pharmaceutical Co [KBYPF] is a Pink Sheet which is traded between brokers as part of OTC trading.

Management Performance

Kobayashi Pharmaceutical Leadership Team

Elected by the shareholders, the Kobayashi Pharmaceutical's board of directors comprises two types of representatives: Kobayashi Pharmaceutical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Kobayashi. The board's role is to monitor Kobayashi Pharmaceutical's management team and ensure that shareholders' interests are well served. Kobayashi Pharmaceutical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Kobayashi Pharmaceutical's outside directors are responsible for providing unbiased perspectives on the board's policies.
Takayuki Kimura, Gen Department
Tetsuji Nishioka, Sr Headquarters
Yoshihiro Ogawa, Sr Division
Naoki Ayabe, GM Area
Satoshi Yamane, Managing Director, Executive Officer, Chief Senior Director of Headquarter Group
Kazumasa Kobayashi, Chairman of the Board, Chairman of Subsidiary, Representative Director
Akihiro Kobayashi, President Executive Officer, Representative Director
Fujito Ohwaki, Sr Division
Kazuhito Miyanishi, Executive Officer, Director of International Business
Takuya Matsushita, Sr Division

Kobayashi Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Kobayashi Pharmaceutical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Consideration for investing in Kobayashi Pink Sheet

If you are still planning to invest in Kobayashi Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kobayashi Pharmaceutical's history and understand the potential risks before investing.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Fundamental Analysis
View fundamental data based on most recent published financial statements
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Commodity Directory
Find actively traded commodities issued by global exchanges